Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Stock
Equities
GENIL
TREGENL00024
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.45 TRY | -0.90% | -3.43% | +28.95% |
Sales 2022 | 5.45B 169M | Sales 2023 | 8.15B 253M | Capitalization | 14.06B 436M |
---|---|---|---|---|---|
Net income 2022 | 1.08B 33.51M | Net income 2023 | 455M 14.12M | EV / Sales 2022 | 2.76 x |
Net cash position 2022 | 494M 15.33M | Net Debt 2023 | 594M 18.43M | EV / Sales 2023 | 1.8 x |
P/E ratio 2022 |
14.4
x | P/E ratio 2023 |
30.9
x | Employees | 622 |
Yield 2022 |
2.15% | Yield 2023 |
-
| Free-Float | 25.82% |
1 day | -0.90% | ||
1 week | -3.43% | ||
1 month | +10.21% | ||
3 months | -15.92% | ||
6 months | +8.92% | ||
Current year | +28.95% |
Managers | Title | Age | Since |
---|---|---|---|
Nadir Ulu
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-30 |
Ali Ketencioglu
IRC | Investor Relations Contact | - | 21-08-31 |
Sales & Marketing | - | 10-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Abidin Gulmus
CHM | Chairman | - | - |
Sukru Turkmen
BRD | Director/Board Member | - | - |
Ömer Dinçer
BRD | Director/Board Member | - | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 60.45 | -0.90% | 804,152 |
24-05-30 | 61 | +1.41% | 804,111 |
24-05-29 | 60.15 | -1.64% | 1,428,249 |
24-05-28 | 61.15 | +0.99% | 874,893 |
24-05-27 | 60.55 | -3.27% | 1,097,271 |
Delayed Quote Borsa Istanbul, May 31, 2024 at 11:08 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+28.95% | 563M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- GENIL Stock